600
Participants
Start Date
December 31, 2003
Primary Completion Date
April 30, 2005
Study Completion Date
April 30, 2005
Ciclesonide
Altana Pharma/Nycomed, Liverpool
Altana Pharma/Nycomed, Pittsburgh
Altana Pharma/Nycomed, Easton
Altana Pharma/Nycomed, Bethesda
Altana Pharma/Nycomed, Richmond
Altana Pharma/Nycomed, Winston-Salem
Altana Pharma/Nycomed, Raleigh
Altana Pharma/Nycomed, Atlanta
Altana Pharma/Nycomed, DeLand
Altana Pharma/Nycomed, Clearwater
Altana Pharma/Nycomed, Cincinnati
Altana Pharma/Nycomed, Cincinnati
Altana Pharma/Nycomed, Milwaukee
Altana Pharma/Nycomed, Normal
Altana Pharma/Nycomed, Overland Park
Altana Pharma/Nycomed, New Orleans
Altana Pharma/Nycomed, Oklahoma City
Altana Pharma/Nycomed, Dallas
Altana Pharma/Nycomed, Houston
Altana Pharma/Nycomed, Kerrville
Altana Pharma/Nycomed, New Braunfels
Altana Pharma/Nycomed, San Antonio
Altana Pharma/Nycomed, Austin
Altana Pharma/Nycomed, Salt Lake City
Altana Pharma/Nycomed, Los Angeles
Altana Pharma/Nycomed, Long Beach
Altana Pharma/Nycomed, Encinitas
Altana Pharma/Nycomed, Vista
Altana Pharma/Nycomed, San Diego
Altana Pharma/Nycomed, San Diego
Altana Pharma/Nycomed, Huntington Beach
Altana Pharma/Nycomed, Newport Beach
Altana Pharma/Nycomed, Mission Viejo
Altana Pharma/Nycomed, Stockton
Altana Pharma/Nycomed, Portland
Altana Pharma/Nycomed, Trumbull
Altana Pharma/Nycomed, North Dartmouth
Altana Pharma/Nycomed, Forked River
Altana Pharma/Nycomed, Skillman
Altana Pharma/Nycomed, Springfield
Altana Pharma/Nycomed, Cranston
Lead Sponsor
AstraZeneca
INDUSTRY